Close Menu

BG Medicine

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage of Fluidigm and BG Medicine, placing a Buy rating on both firms.

BG Medicine said this week that revenues for the second quarter increased 181 percent year over year, rising to $622,000 from $221,000 a year ago and beating the average Wall Street estimate of $520,000.

NEW YORK (GenomeWeb News) – BG Medicine said today that revenues for the second quarter increased 181 percent year over year, surpassing the consensus Wall Street estimates on the top and bottom line.

BG Medicine said last week that it filed a 510(k) submission with the US Food & Drug Administration for an automated version of its BGM Galectin-3 heart failure test to be run on Abbott Laboratories' Architect platform.

At a meeting hosted by the Centers for Medicare & Medicaid Services this week to determine payment levels for genetic tests placed in the clinical laboratory fee schedule, lab industry professionals remained at loggerheads with pathologists who maintained that the physician f

Provista Diagnostics has formed its scientific advisory board, appointing Karen Anderson, Carlos Arteaga, Robert Benezra, Andrew Dannenberg, and Joshua LaBaer.

Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Korber European Science Prize for his work in proteomics.
The prize, which will be present on Sept. 7, comes with a €750,000 ($940,000) award.

People in the News

NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.

BG Medicine this week reported a 44 percent drop in first-quarter revenues year over year as its service revenues fell but its product revenues rose sharply.

NEW YORK (GenomeWeb News) – BG Medicine reported a 44 percent drop in first-quarter revenues year over year as its service revenues plummeted but its product revenues rose sharply.

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.